Succession Attack Plan: Get Strategic with Your Critical Roles
Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.
Related content
Resistance doesn’t end after kickoff—it evolves. To lead lasting transformation, CEOs must stop treating pushback as failure and start using it as fuel.
lorem ipsum
Despite the high stakes, more than half of boards and CEOs are not confident their succession planning is adequate.
lorem ipsum
How pharma and biotech leaders can navigate today’s challenging landscape—focusing on revamped approaches in business operations, talent strategy and development, and more to meet the evolving demands.
lorem ipsum
Related content
En un contexto marcado por la inteligencia artificial y el cambio constante, BTS incorpora un nuevo marco para fortalecer la capacidad de adaptación, aprendizaje y liderazgo de las organizaciones.
lorem ipsum
‘Constructive disagreement’ is the hidden catalyst of group innovation. Here’s how to get your organization there.
lorem ipsum
How CEOs can win at applied AI by trusting teams to reinvent their work, setting AI flywheels in motion, and scaling breakthroughs from the frontlines.
lorem ipsum